Preoperative acute normovolemic hemodilution: a meta-analysis.
Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E
Transfusion 2004;44(5):632-644.
Review by
The use of recombinant factor VIIa in children with inherited platelet function disorders.
Almeida AM, Khair K, Hann I, Liesner R
Br J Haematol 2003;121(3):477-481.
Review by Aldouri M
Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections.
Matot I, Scheinin O, Jurim O, Eid A
Anesthesiology 2002;97(4):794-800.
Review by Van der Linden P, Messmer K
Experience with use of recombinant activated factor VII.
Divanon F, Hecquard C, Borel-Derlon A
J Clin Pharm Ther 2002;27(2):133-138.
Review by
Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions.
Lieberthal W, Fuhro R, Alam H, et al.
Shock 2002;17(1):61-69.
Review by
Oxygen transport dynamics of acellular hemoglobin solutions in an isovolemic hemodilution model in swine.
Vaslef SN, Kaminski BJ, Talarico TL
J Trauma 2001;51(6):1153-1160.
Review by Van der Linden P.
New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.
Kessler CM
Curr Opin Hematol 2000;7(6):408-413.
Review by M. Aldouri